Continuous Local-anesthetic Wound Infusion for Neck Dissection
NCT06201039
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Cancer
Interventions
DRUG:
0.5% Lidocaine Hydrochloride
DRUG:
0.9% Normal Saline
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University